Redsense Medical (Sweden) Performance
| REDS Stock | SEK 7.16 0.08 1.13% |
Redsense Medical has a performance score of 3 on a scale of 0 to 100. The company holds a Beta of 0.36, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Redsense Medical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Redsense Medical is expected to be smaller as well. Redsense Medical right now holds a risk of 4.41%. Please check Redsense Medical standard deviation, total risk alpha, and the relationship between the coefficient of variation and jensen alpha , to decide if Redsense Medical will be following its historical price patterns.
Risk-Adjusted Performance
3 of 100
Weak | Strong |
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Redsense Medical AB are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Redsense Medical may actually be approaching a critical reversion point that can send shares even higher in January 2025. ...more
Redsense |
Redsense Medical Relative Risk vs. Return Landscape
If you would invest 680.00 in Redsense Medical AB on September 5, 2024 and sell it today you would earn a total of 36.00 from holding Redsense Medical AB or generate 5.29% return on investment over 90 days. Redsense Medical AB is generating 0.1714% of daily returns and assumes 4.4141% volatility on return distribution over the 90 days horizon. Simply put, 39% of stocks are less volatile than Redsense, and 97% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Redsense Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Redsense Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Redsense Medical AB, and traders can use it to determine the average amount a Redsense Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0388
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | REDS | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.41 actual daily | 39 61% of assets are more volatile |
Expected Return
| 0.17 actual daily | 3 97% of assets have higher returns |
Risk-Adjusted Return
| 0.04 actual daily | 3 97% of assets perform better |
Based on monthly moving average Redsense Medical is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Redsense Medical by adding it to a well-diversified portfolio.
Redsense Medical Fundamentals Growth
Redsense Stock prices reflect investors' perceptions of the future prospects and financial health of Redsense Medical, and Redsense Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Redsense Stock performance.
| Price To Earning | (50.14) X | |||
| EBITDA | (6.68 M) | |||
| Cash And Equivalents | 3.12 M | |||
| Cash Per Share | 0.28 X | |||
| Total Debt | 3.04 M | |||
| Debt To Equity | 75.30 % | |||
| Book Value Per Share | 0.37 X | |||
| Cash Flow From Operations | (7.09 M) | |||
| Earnings Per Share | (0.63) X | |||
About Redsense Medical Performance
Assessing Redsense Medical's fundamental ratios provides investors with valuable insights into Redsense Medical's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Redsense Medical is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Redsense Medical AB provides blood loss detection devices primarily in Europe and the United States. Redsense Medical AB was founded in 2000 and is headquartered in Halmstad, Sweden. Redsense Medical is traded on Stockholm Stock Exchange in Sweden.Things to note about Redsense Medical performance evaluation
Checking the ongoing alerts about Redsense Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Redsense Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Redsense Medical had very high historical volatility over the last 90 days | |
| Redsense Medical has accumulated kr3.04 Million in debt which can lead to volatile earnings | |
| Net Loss for the year was (6.94 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Redsense Medical AB has accumulated about 3.12 M in cash with (7.09 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.28. |
- Analyzing Redsense Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Redsense Medical's stock is overvalued or undervalued compared to its peers.
- Examining Redsense Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Redsense Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Redsense Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Redsense Medical's stock. These opinions can provide insight into Redsense Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Redsense Stock Analysis
When running Redsense Medical's price analysis, check to measure Redsense Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Redsense Medical is operating at the current time. Most of Redsense Medical's value examination focuses on studying past and present price action to predict the probability of Redsense Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Redsense Medical's price. Additionally, you may evaluate how the addition of Redsense Medical to your portfolios can decrease your overall portfolio volatility.